Clinical Trials Sponsored by innoVactiv Inc.

Total 36028 results

French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Active, not recruiting

Study Impact on Outcome of Eltrombopag in Elderly Patients With Acute Myeloid Leukemia Receiving Induction Chemotherapy (EPAG2015)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Terminated

The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line

Essential Thrombocythemia

France
Foundation for Innovative New Diagnostics, Switzerland

Unknown

Performance Evaluation of Malaria Plus RDTs

Malaria
University of Edinburgh
Innovative Medicines Initiative

Terminated

European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS) (EPAD-LCS)

Alzheimer's Dementia

United Kingdom, Belgium, France, Greece, Italy, Netherlands, Spain, Sweden, Switzerland
Novartis Pharmaceuticals
Innovative Medicines Initiative

Withdrawn

Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD. (PROactive)

COPD
Foundation for Innovative New Diagnostics, Switzerland

Recruiting

BGM and HbA1c POC Device Evaluation

Diabetes

Nigeria, Cambodia, Colombia
Foundation for Innovative New Diagnostics, Switzerland

Completed

COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

COVID-19 Respiratory Infection

Switzerland, Uganda, United Kingdom
Foundation for Innovative New Diagnostics, Switzerland

Completed

Clinical Evaluation of tNGS for Diagnosis of DR-TB (Seq&Treat)

Tuberculosis, Multidrug-Resistant

Georgia, India, South Africa
French Innovative Leukemia Organisation
Janssen, LP

Active, not recruiting

Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction (IDA53)

Relapsed or Refractory Chronic Lymphocytic Leukemia

France
Center for Innovative Public Health Research

Unknown

Girl2Girl: A Web-based Trial (G2G)

Pregnancy Prevention

United States
Foundation for Innovative New Diagnostics, Switzerland

Completed

Actionable Results: Bloodstream Infection Molecular Assay Evaluation

Bloodstream Infection

Botswana
Foundation for Innovative New Diagnostics, Switzerland

Completed

Prospective Assessment of TBDx Feasibility

Pulmonary Tuberculosis

Vietnam, Peru
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Completed

Phase I Study in RAD 001 Patients With Relapse AML

AML

France
Complexa, Inc.
Medpace, Inc.; Allegheny Singer Research Institute (also known as Allegheny... and other collaborators

Terminated

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

PAH

United States, United Kingdom
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Innovative Cardiovascular Solutions
Yale Cardiovascular Research Group

Recruiting

Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Insufficiency | Aortic Valve Replacement

United States
Pfizer
Innovative Medicines Initiative (IMI) COMBACTE-CARE

Completed

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Complicated Intra-Abdominal Infections, cIAIs

Spain, France, Germany
French Innovative Leukemia Organisation
Roche Pharma AG

Completed

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

B-cell Chronic Lymphocytic Leukemia CLL

France
University Hospital, Angers
French Innovative Leukemia Organisation

Unknown

Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia

Adult Acute Lymphoblastic Leukemia

France
Sciema UG
Innovative Diabetes Treatment Studies LLC.

Completed

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States, Germany
Sciema UG
Innovative Diabetes Treatment Studies LLC.

Active, not recruiting

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany, United States
Zhejiang University
Innovative Cellular Therapeutics Co., Ltd.

Unknown

CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma

Lymphoma

China
University of Surrey
GlaxoSmithKline; Innovative Medicines Initiative

Completed

Training Study to Characterise Biomarkers to the Engerix B Vaccine

Healthy

United Kingdom
French Innovative Leukemia Organisation
Hoffmann-La Roche

Completed

Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

Mantle Cell Lymphoma

France
Innovative Humanitarian Solutions
University of Houston - Victoria

Unknown

Antioxidant Supplementation in Patients With Kashin-Beck Disease

Kashin-Beck Disease

China
French Innovative Leukemia Organisation
Hoffmann-La Roche

Recruiting

Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome (GLORIFY)

Richter Syndrome

France
French Innovative Leukemia Organisation
University Hospital, Lille

Recruiting

Observatory of Prolymphocytic Leukemia T (T-PLL)

Prolymphocytic Leukemia | T-cell Leukemia

France
French Innovative Leukemia Organisation
Bristol-Myers Squibb

Completed

REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy (RESIST)

Small Lymphocytic Leukemia | CLL, Relapsed | CLL, Refractory | Bruton Tyrosine Kinase Inhibitor

France
University Hospital, Toulouse
French Innovative Leukemia Organisation

Completed

Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients (LAM-RAPA)

Acute Myeloid Leukemia

France
Foundation for Innovative New Diagnostics, Switzerland
UNITAID

Completed

Evaluation of Dried Blood Spot for HCV RNA Testing

Hepatitis C, Chronic

Australia, Cameroon, Georgia, Greece, Rwanda
French Innovative Leukemia Organisation
Lymphoma Study Association

Completed

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

Mantle Cell Lymphoma

France
French Innovative Leukemia Organisation
Mundipharma Pte Ltd.

Completed

Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma (BENTLY)

T-cell Lymphoma

France
University Hospital, Grenoble
French Innovative Leukemia Organisation

Completed

Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma (LTP)

Peripheral T Cell Lymphoma

France
French Innovative Leukemia Organisation
Novartis; Schering SA

Completed

GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly

Acute Myeloid Leukemia

France
German Centre for Assessment and Evaluation of...

Not yet recruiting

Application of Dried Human Amnion Graft to Improve Postprostatectomy Incontinence and Potency

Complication | Continence | Potency | Biochemical Recurrence

Germany
St. Jude Children's Research Hospital
Eisai Inc.; Medicines for Malaria Venture; Global Health Innovative Technology...

Completed

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Malaria

United States
Innovative Chemical and Environmental Technologies...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

A Trial for the Safety and Effectiveness of a Novel Antimicrobial-Coated Foley Catheter for Reduction of CAUTI.

Urinary Tract Infection

United States
University of Oxford
Innovative Medicines Initiative; Respiratory syncytial virus consortium in...

Active, not recruiting

Understanding RSV: Severe Disease and the Long Term Consequences

Respiratory Syncytial Virus (RSV)

United Kingdom
French Innovative Leukemia Organisation
Acute Leukemia French Association

Not yet recruiting

Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine (VENAZA)

AML, Adult

France
Universitaire Ziekenhuizen KU Leuven
Innovative Medicines Initiative; BELpREG

Recruiting

UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk (UmbrelLACT)

Breast Feeding | Human Milk

Belgium
French Innovative Leukemia Organisation
Acute Leukemia French Association

Not yet recruiting

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

AML, Adult

France
Children's Hospital of Orange County
Innovative Health Solutions

Recruiting

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

COVID-19 | Post-Concussion Syndrome | COVID Long-Haul

United States
University of California, Los Angeles
Innovative Health Solutions

Recruiting

Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome

Irritable Bowel Syndrome | Abdominal Pain | Autonomic Nervous System Imbalance

United States
Foundation for Innovative New Diagnostics, Switzerland
Australian Government

Completed

Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care Testing

Malaria | Diagnoses Disease | RDT

Rwanda
French Innovative Leukemia Organisation
Acute Leukemia French Association

Completed

A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE (ELEGANCE)

Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
French Innovative Leukemia Organisation
AbbVie; Janssen-Cilag Ltd.

Active, not recruiting

Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia (ERADIC)

Intermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven Strategy

France
French Innovative Leukemia Organisation
Acute Leukemia French Association

Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (OGILAR)

AML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
Morris Innovative Incorporated
Deborah Heart and Lung Center

Unknown

EndovascuLar RegIstry Evaluating SafeTy, Efficacy and Patient Comfort (ELITE) (ELITE)

Vascular Diseases

United States
French Innovative Leukemia Organisation

Unknown

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Lymphoma
French Innovative Leukemia Organisation

Unknown

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

Lymphoma

Clinical Trials Sponsored by innoVactiv Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations